Pacific Biosciences (PACB) Stock Price, Quote, News & History | Benzinga

Pacific Biosciences of California Inc (PACB) Stock Price, Quote, News & History

PACBNASDAQ

Trade with Public

Trade with Public

$1.40

-0.15-9.68%

At close: Aug 28, 5:00 PM EST

$1.42

0.021.43%

After Hours: Aug 28, 7:48 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.52

Close

$1.40

Volume / Avg.

5.23M / 6.75M

Day Range

$1.39 - $1.55

52 Wk Range

1.07 - 2.73

Market Cap

$441.38M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

19.75%

Days to Cover

6.63

Recent Pacific Biosciences of California, Inc. News

Nayax, Immatics, Moderna, Marvell Technology And Other Big Stocks Moving Higher On Tuesday

Nasdaq: NYAX rose 13.9% on Tuesday after announcing acquisition of IPS Group Inc. for $350 million. Other big gainers include CAPR, RZLV, CRML, and MAIR.

Avi Kapoor

Cathie Wood Sells Robinhood Stock, Doubles Down On This George Soros-Backed AI Stock

On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,502 shares of Kodiak AI

Shivdeep Dhaliwal

Cathie Wood's Biotech Trend: Twist, Beam, CRISPR Latest Stock Picks

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the year of the genomic revolution.

Erica Kollmann

Novo Nordisk, Waldencast And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Avi Kapoor

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-118.05M

Investing Cash Flow (TTM)

120.86M

Financing Cash Flow (TTM)

3.16M

Free Cash Flow (TTM)

-130.48M

Capital Expenditure (TTM)

-12.43M

Net Change in Cash (TTM)

5.97M

Analyst Trends and Forecast

1

Mar

1

Apr

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$902.86M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

2.67

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-30.11%

Earnings Yield % (FWD)

-37.28%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.11

Company Debt

Total Debt

$644.33M

LT Debt

$644.33M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$61.00M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$1.52

Close

$1.40

Volume / Avg.

5.23M / 6.75M

Day Range

$1.39 - $1.55

52 Wk Range

1.07 - 2.73

Market Cap

$441.38M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

19.75%

Days to Cover

6.63

About

Sector

Health Care

Industry

Life Sciences Tools & Services

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, res...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Pacific Biosciences (PACB) stock?

A

You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pacific Biosciences (PACB) competitors?

A

Other companies in Pacific Biosciences’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).

Q

What is the forecast, or price target, for Pacific Biosciences (PACB) stock?

A

Pacific Biosciences has a consensus price target of $2.38.

Q

What is the current price for Pacific Biosciences (PACB)?

A

The stock price for Pacific Biosciences (NASDAQ: PACB) is $1.42 last updated August 28, 2026 at 7:48 PM EDT.

Q

Does Pacific Biosciences (PACB) pay a dividend?

A

There are no upcoming dividends for Pacific Biosciences.

Q

When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?

A

Pacific Biosciences does not have any upcoming earnings scheduled.

Q

Is Pacific Biosciences (PACB) going to split?

A

There is no upcoming split for Pacific Biosciences.

Q

What sector and industry does Pacific Biosciences (PACB) operate in?

A

Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.